CIK 0001420565
- Non-accelerated filer
- Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 134196017
- Phone
- +1 737-802-1989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 6,607 shares at an average $3.26 ($21,568)
- 4 Open-market sale 10% owner sold 24,671 shares at an average $3.27 ($80,710)
- 4 Open-market sale 10% owner sold 12,315 shares at an average $3.29 ($40,528)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market sale 10% owner sold 20,315 shares at an average $4.21 ($85,473)
- 4 Open-market sale 10% owner sold 31,151 shares at an average $4.47 ($139,103)
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and COO acquired 2,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and COO bought 225 shares at $3.37 ($758)
- 4 Open-market buy President and COO bought 5,076 shares at $1.97 ($9,987)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 2 of 11 · 208 filings